TY - JOUR AU - Pirelli, Luigi AU - Hong, Estee AU - Steffen, Robert AU - Vahl, Torsten P. AU - Kodali, Susheel K. AU - Bapat, Vinayak PY - 2021 TI - Mitral valve-in-valve and valve-in-ring: tips, tricks, and outcomes JF - Annals of Cardiothoracic Surgery; Vol 10, No 1 (January 29, 2021): Transcatheter Mitral Valve Replacement Y2 - 2021 KW - N2 - Transcatheter aortic valve implantation is now a mainstay of treatment in patients with aortic stenosis who are considered intermediate, high and prohibitive risk for surgery. Extended use of this innovative platform in treating other conditions has led to its approval in treating degenerated aortic bioprosthesis. Similarly, use of transcatheter devices in treating degenerated mitral bioprosthesis and failed mitral valve repairs with annuloplasty rings has opened a potential alternative to surgery in these patients. Experience in mitral valve-in-valve (MVIV) and valve-in-ring (VIR), while still limited, is on the rise. Although similar in many ways to the aortic VIV, it is different with respect to patient selection, planning and procedural steps. Familiarity with the bioprosthetic properties and dimensions can help an operator choose an appropriate transcatheter device and deploy it in an ideal position. Due to greater variability in construction and properties, mitral rings have led to poorer results compared to mitral valve-in valve. Understanding the properties of mitral rings is critical and has been simplified by us in a stepwise manner. We also describe steps in patient preparation and procedure, which should help operators in performing this procedure. Certain unique complications, such as left ventricular outflow tract obstruction and risk of embolization, are discussed with tips to address these issues. Once these steps are followed, the procedure can be performed with minimal risk and good outcome. UR - https://www.annalscts.com/article/view/16790